SCHEMBL969094

SCHEMBL969094

Cc1ccc2c3c(sc2n1)CN(CC(=O)N1CCN(C2CCC2)CC1)CC3

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.44
USP28 Q96RU2 1/20 0.42
USP25 Q9UHP3 1/20 0.42
ALDH1A1 P00352 8/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 2/20 0.39
G6PD P11413 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
HSD17B10 Q99714 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HRH3 Q9Y5N1 3/20 0.37
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
RGS12 O14924 1/20 0.34
BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12920055 0.91 PARP1 (0.41) PARP1USP28USP25ALDH1A1KDM4E
SCHEMBL13985865 0.88 PARP1 (0.43) PARP1USP28USP25ALDH1A1KDM4E
SCHEMBL971043 0.87 PARP1 (0.43) PARP1ALDH1A1KDM4EHPGDHRH3
SCHEMBL968525 0.86 PARP1 (0.43) PARP1ALDH1A1KDM4EHPGDMAPT
SCHEMBL966767 0.86 PARP1 (0.40) PARP1ALDH1A1KDM4EHPGDMAPT
SCHEMBL970417 0.84 PARP1 (0.40) PARP1ALDH1A1KDM4EHPGDMAPT
SCHEMBL968990 0.84 KDM4E (0.41) PARP1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13985958 0.84 MEN1 (0.36) ALDH1A1KDM4EHPGDMAPTHRH3
SCHEMBL967160 0.84 PARP1 (0.40) PARP1ALDH1A1KDM4EHPGDMAPT
SCHEMBL968565 0.83 PARP1 (0.39) PARP1ALDH1A1KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PARP1 2898/4885USP28 3560/4885USP25 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.